NovaBridge Biosciences
(NASDAQ) NBP
NovaBridge Biosciences Financials at a Glance
Market Cap
$219.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$19.88M
EPS (TTM)
-$0.44
P/E Ratio
-4.30
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$1.90
Volume
483,148.447
Open
$1.87
Price
$1.90
Volume
483,148.447
Open
$1.87
Previous Close
$1.90
Daily Range
$1.75 - $1.91
52-Week Range
$1.46 - $6.79
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$1.90
Volume
483,148.447
Open
$1.87
Previous Close
$1.90
Daily Range
$1.75 - $1.91
52-Week Range
$1.46 - $6.79
Estimated Earnings Date
Jul 30, 2026
NBP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NovaBridge Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
30
CEO
Xi-Yong Fu, PhD, MBA
Website
www.i-mabbiopharma.comHeadquarters
Rockville, MD 20850, US
NBP Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-0.59%
Return on Capital
-40.28%
Return on Assets
-53.39%
Earnings Yield
-23.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$219.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
115.38M
Volume
483.15K
Avg. Volume
884.34K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$31.79M
EBITDA
-$31.54M
Operating Cash Flow
-$1.45M
Capital Expenditure
$41.00
Free Cash Flow
-$1.45M
Cash & ST Invst.
$30.14M
Total Debt
$438.46K
NovaBridge Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$219.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$7.31M
N/A
Employees
30
N/A
Net Income
-$4.40M
+51.4%
EBITDA
-$10.39M
+89.3%
Quarterly Fundamentals
Total Cash
$30.14M
-97.6%
Total Debt
$438.46K
-98.5%
Accounts Receivable
$256.33K
N/A
Inventory
$0.00
N/A
Long Term Debt
$311.08K
-98.6%
Short Term Debt
$127.38K
-97.9%
Return on Assets
-53.39%
N/A
Return on Invested Capital
-95.18%
N/A
Free Cash Flow
-$14.60M
N/A
Operating Cash Flow
-$14.60M
N/A